Reduced Cardiovascular Mortality 10 Years after Supplementation with Selenium and Coenzyme Q10 for Four Years: Follow-Up Results of a Prospective Randomized Double-Blind Placebo-Controlled Trial in Elderly Citizens

Abstract

BackgroundSelenium and coenzyme Q10 are important antioxidants in the body. As the intake of selenium is low in Europe, and the endogenous production of coenzyme Q10 decreases as age increases, an intervention trial using selenium and coenzyme Q10 for four years was performed. As previously reported, the intervention was accompanied by reduced cardiovascular mortality. The objective of the present study was to analyze cardiovascular mortality for up to 10 years after intervention, to evaluate if mortality differed in subgroups differentiated by gender, diabetes, ischemic heart disease (IHD), and functional class.MethodsFour-hundred forty-three healthy elderly individuals were included from a rural municipality in Sweden. All cardiovascular mortality was registered, and no participant was lost to the follow-up. Based on death certificates and autopsy results mortality was registered.FindingsSignificantly reduced cardiovascular mortality could be seen in those on selenium and coenzyme Q10 intervention. A multivariate Cox regression analysis demonstrated a reduced cardiovascular mortality risk in the active treatment group (HR: 0.51; 95%CI 0.36–0.74; P = 0.0003). The reduced mortality could be seen to persist during the 10-year period. Subgroup analysis showed positive effects in both genders. An equally positive risk reduction could be seen in those with ischemic heart disease (HR: 0.51; 95%CI 0.27–0.97; P = 0.04), but also in the different functional classes.ConclusionsIn a 10-year follow-up of a group of healthy elderly participants given four years of intervention with selenium and coenzyme Q10, significantly reduced cardiovascular mortality was observed. The protective action was not confined to the intervention period, but persisted during the follow-up period. The mechanism explaining the persistency remains to be elucidated. Since this was a small study, the observations should be regarded as hypothesis-generating.

Influence of Chronic Coenzyme Q10 Supplementation on Cognitive Function, Learning, and Memory in Healthy and Diabetic Middle-Aged Rats

“…The beneficial effects of CoQ10 supplementation on the diabetes-induced abnormalities and complications in diabetic patients receiving regular medications have been revealed in several clinical trials [80-85]. In addition, combination therapy exerts more beneficial effects in the treatment of diabetes-related complications.…”

Selenium in Cardiac Surgery

“…In this context, a prospective randomized, double‐blind, placebo‐controlled study evaluated the effects of combined chronic supplementation of Se (200 μg organic Se) and 200 mg coenzyme Q10 per day on the severity of chronic heart failure, all‐cause mortality, and cardiovascular mortality . The intervention was performed for 4 years, and the authors observed that chronic treatment with Se and Q10 resulted in a reduced inflammatory status in these patients and significantly reduced cardiovascular mortality assessed after 10 years …”

“…The administration of low doses of Se at only a few time points will probably have no significant effects on the circulating Se blood levels, bioavailability, or the patient's clinical outcome . In contrast, a more frequent administration of Se might have more pronounced effects on reducing new infections in critically ill patients . Additionally, there is no consensus about whether Se should be administered as a bolus or as a continuous infusion.…”

Less fibrosis in elderly subjects supplemented with selenium and coenzyme Q10—A mechanism behind reduced cardiovascular mortality?

“…It should be noted that those who had received active intervention and were included in the study had only been treated for the initial 48 months. But as previously reported, a significant cardioprotective effect remained also after 10 years [53]. It is tempting to speculate if a prevention of structural changes induced by the decelerated fibrogenesis explains this long-lasting cardioprotection.…”